InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Harmony Biosciences Holdings, Inc.

HRMY Clue Score72
United States Fiscal year ends December CIK 0001802665 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Mostly scheduled

Individual transactions

13
Insider
Date
Role
Action
Shares
Price
Amount
Kumar Budur
18 Sep 2026
Chief Medical Officer
Sold after exercise
35,852
$43.05
$1.54M
Kumar Budur
17 Sep 2026
Chief Medical Officer
Sold after exercise
800
$43.00
$34.40K
Kumar Budur
16 Sep 2026
Chief Medical Officer
Sold after exercise
1,800
$43.01
$77.43K
Kumar Budur
8 Sep 2026
Chief Medical Officer
Sold after exercise
22,954
$43.10
$989.35K
Kumar Budur
8 Sep 2026
Chief Medical Officer
Sold after exercise
1,000
$42.79
$42.79K
Kumar Budur
8 Sep 2026
Chief Medical Officer
Sold after exercise
4,500
$42.25
$190.11K
Kumar Budur
4 Sep 2026
Chief Medical Officer
Sell
5,500
$41.98
$230.91K
Sandip Kapadia
26 Jan 2026
Chief Financial Officer
Sold on a plan
3,746
$37.15
$139.17K
Sandip Kapadia
15 Jan 2026
Chief Financial Officer
Sold on a plan
20,961
$35.92
$752.83K
Jeffrey M. Dayno
12 Dec 2025
President, CEO
Sold after exercise
5,933
$40.11
$237.96K
Jeffrey M. Dayno
12 Dec 2025
President, CEO
Sold after exercise
20,000
$40.11
$802.15K
Sandip Kapadia
5 Dec 2025
Chief Financial Officer
Sold after exercise
20,000
$39.54
$790.90K
Sandip Kapadia
21 Nov 2025
Chief Financial Officer
Sold on a plan
3,427
$35.00
$119.95K

What was left out

Form 4 filings counted 23
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 9
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 201,697
History held since 20 Aug 2020